scholarly journals Diagnostic determinants for capillary leakage syndrome (CLS) in septic shock patients

Critical Care ◽  
10.1186/cc510 ◽  
1999 ◽  
Vol 3 (Suppl 1) ◽  
pp. P136
Author(s):  
G Marx ◽  
C Burczyk ◽  
M Cobas Meyer ◽  
B Vangerow ◽  
N Maassen ◽  
...  
Keyword(s):  
Septic Shock ◽  
Capillary Leakage ◽  
Capillary Leakage Syndrome

Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients

2000 ◽  
Vol 26 (9) ◽  
pp. 1252-1258 ◽  
Author(s):  
G. Marx ◽  
B. Vangerow ◽  
C. Burczyk ◽  
K.F. Gratz ◽  
N. Maassen ◽  
...  
Keyword(s):  
Septic Shock ◽  
Capillary Leakage ◽  
Capillary Leakage Syndrome

scholarly journals Isolated “puffy hands” following COVID-19: clue to a long-term capillary leakage syndrome?

2021 ◽  
Author(s):  
Jacopo Ciaffi ◽  
Riccardo Meliconi ◽  
Piero Ruscitti ◽  
Annamaria Iagnocco ◽  
Clodoveo Ferri ◽  
...  
Keyword(s):  
Capillary Leakage ◽  
Capillary Leakage Syndrome

RESUSCITATION FROM SEPTIC SHOCK WITH CAPILLARY LEAKAGE: HYDROXYETHYL STARCH (130 KD), BUT NOT RINGER’S SOLUTION MAINTAINS PLASMA VOLUME AND SYSTEMIC OXYGENATION

Shock ◽  
2004 ◽  
Vol 21 (4) ◽  
pp. 336-341 ◽  
Author(s):  
Gernot Marx ◽  
Samantha Pedder ◽  
Linda Smith ◽  
Seshapillai Swaraj ◽  
Steve Grime ◽  
...  
Keyword(s):  
Septic Shock ◽  
Hydroxyethyl Starch ◽  
Plasma Volume ◽  
Capillary Leakage ◽  
Ringer’S Solution

Terminal complement complex in septic shock with capillary leakage

2005 ◽  
Vol 22 (7) ◽  
pp. 541-547 ◽  
Author(s):  
T. Schuerholz ◽  
M. Leuwer ◽  
M. Cobas-Meyer ◽  
B. Vangerow ◽  
F. Kube ◽  
...  
Keyword(s):  
Septic Shock ◽  
Capillary Leakage ◽  
Terminal Complement Complex ◽  
Terminal Complement

Risk factors for capillary leakage syndrome after bone marrow transplantation

1997 ◽  
Vol 74 (5) ◽  
pp. 221-224 ◽  
Author(s):  
W. Nürnberger ◽  
R. Willers ◽  
S. Burdach ◽  
U. Göbel
Keyword(s):  
Risk Factors ◽  
Bone Marrow ◽  
Bone Marrow Transplantation ◽  
Marrow Transplantation ◽  
Capillary Leakage ◽  
Capillary Leakage Syndrome

Attenuation of capillary leakage by hydroxyethyl starch (130/0.42) in a porcine model of septic shock

2006 ◽  
Vol 34 (12) ◽  
pp. 3005-3010 ◽  
Author(s):  
Gernot Marx ◽  
Samantha Pedder ◽  
Linda Smith ◽  
Seshapillai Swaraj ◽  
Steve Grime ◽  
...  
Keyword(s):  
Septic Shock ◽  
Hydroxyethyl Starch ◽  
Porcine Model ◽  
Capillary Leakage

Interleukin 11 Induced Capillary Leakage Syndrome and Deteriorated Hemorrhagic Cystitis in an Acute Myelogenous Leukemia Patient after Allo-HSCT.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 4997-4997
Author(s):  
Xuemei Sun ◽  
Yonggong Yang ◽  
Chaoyang Guan ◽  
Xiaohui Li
Keyword(s):  
Renal Failure ◽  
Acute Renal Failure ◽  
Acute Myelogenous Leukemia ◽  
Hemorrhagic Cystitis ◽  
Myelogenous Leukemia ◽  
Capillary Leakage ◽  
Urinary Volume ◽  
Acute Myelogenous ◽  
Interleukin 11 ◽  
Capillary Leakage Syndrome

Abstract Interleukin 11 (IL11) has been approved for clinical utilization by Chinese Drug and Food Administration in the treatment of thrombopenia post chemo/radio therapy. It has been proved a safe cytokine in previous clinical trials. We however found a case who presented with a severe syndrome which was suspected in relation with IL 11. A 38- year-old male was undertaken a matched unrelated peripheral blood stem cell transplantation after an ablative BuCy conditioning for the treatment of acute myelogenous leukemia. He suffered from hemorrhagic cystitis(HC) on day 40 and was managed well with aggressive hydration and diuresis as well as administration of anti-virus regimen. After a resultant pancytopenia occurred, he was given IL11 for the amelioration of the thrombocytopenia in aid of controlling the bladder bleeding. His HC was in good control initially, but two days after the IL-11 administering, the patient manifested with generalized edema, hypotension with hemoconcentration and hypoalbuminemia without albuminuria. The diagnosis of capillary leakage syndrome (CLS) was under consideration. Interleukin 11 was ceased immediately and 6% hydroxyethly starch(HES) was added to improve the symptoms of CLS. In the following day the 24 hour- urinary volume of the patient reduced sharply accompanying by dysuresia. Ultrasonic examination displayed a clumping mass measured 50 mm×75mm ×63mm. Three days later, he was diagnosed as acute renal failure owing to combination factors of the renal and/or postrenal damage of the kidney. Meanwhile continuous renal replacement therapy (CRRT) was started and patient got well 5 days later with normal urinary volume. And symptoms from HC and CLS were improved dramatically. We concluded here that interleukin 11 could play the pivotal role in inducing a CLS and resultant acute renal failure. And it thus deteriorated HC in this patient. The patient’s renal function could recover well rapidly with the infusion of HES and CRRT. We suggested a comprehensive clinical study of Interleukin 11 be conducted to optimize its clinical usage for the sake of safe medication.

Sign in / Sign up

Export Citation Format

Share Document